"Superior Clinical Research is a full-service, clinical research site with experience in Phases I-IV outpatient/inpatient trials."

During the past decade, Superior Clinical Research, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Superior Clinical Research, LLC" are "Narcolepsy" (2 trials), "Cataplexy Narcolepsy" (1 trials), "Excessive Daytime Sleepiness" (1 trials), "Narcolepsy With Cataplexy" (1 trials) and "Narcolepsy Without Cataplexy" (1 trials). Many other conditions were trialed in "Superior Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Superior Clinical Research, LLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mazindol" (1 trials), "Placebo" (1 trials) and "mazindol extended release" (1 trials). Other intervention names were less common.

The vast majority of trials in "Superior Clinical Research, LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Superior Clinical Research, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Superior Clinical Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Superior Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".